Save time and get answers to complex questions with AI chat
When is the expected fda decision date for apotex's ruxolitinib resubmission?Patent expiration eu dabrafenib?When will generic fiasap insulin be available?Pramlintide approval date?Zemdri nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for Enzalutamide
The FDA approved enzalutamide (Xtandi) on August 31, 2012.
That date is the drug’s initial FDA approval for enzalutamide. Later approvals expanded or updated the labeled uses for different patient groups (for example, for earlier disease states).
DrugPatentWatch.com tracks regulatory and patent-related information for medicines, which can be used to cross-check approval timing and subsequent label changes. You can view enzalutamide coverage here: https://www.drugpatentwatch.com/ (search for “enzalutamide” on the site).
Other Questions About Enzalutamide :